Skip to main content
Fig. 8 | BMC Cancer

Fig. 8

From: Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis

Fig. 8

Trial identification and inclusion in the systematic review of irinotecan-based chemotherapy efficacy in different ethnicities: The literature was selected according to the criteria as follows: (1) NSCLC patients with previously untreated with chemotherapy; (2) treated with irinotecan-based doublet regimen; (3) prospective clinical trials Phase II and III

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us